808

Vaxcyte Announces Closing of $690 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Friday, October 28, 2022
808, Bank of America, State Street, SEC, Company, Security (finance), U.S. Securities and Exchange Commission, Guggenheim Partners, BofA Securities, Madison Avenue, Prospectus, Sutro Biopharma, Jefferies, Vaccine, 3rd Floor, PCV, Floor, Jefferies Group, Antigen, GLOBE, LLC, Needham & Company, Infection, Attention, Genetically modified bacteria, Equity capital markets, Telephone, SAN, Periodontal disease, Guggenheim, Sale, Exercise

This includes the exercise in full by the underwriters of their option to purchase up to 2,812,500additional shares of common stock at the public offering price per share, less underwriting discounts and commissions.

Key Points: 
  • This includes the exercise in full by the underwriters of their option to purchase up to 2,812,500additional shares of common stock at the public offering price per share, less underwriting discounts and commissions.
  • The aggregate gross proceeds to Vaxcyte from this offering were approximately$690.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by Vaxcyte.
  • BofA Securities, Jefferies, SVB Securities, Evercore ISI and Guggenheim Securities acted as joint book-running managers for the offering.
  • Vaxcyte is driven to eradicate or treat invasive bacterial infections, which have serious and costly health consequences when left unchecked.

Vaxcyte Announces Pricing of $600 Million Public Offering

Retrieved on: 
Wednesday, October 26, 2022
808, Bank of America, State Street, SEC, Company, Security (finance), U.S. Securities and Exchange Commission, Guggenheim Partners, BofA Securities, Madison Avenue, Prospectus, Sutro Biopharma, Jefferies, Vaccine, 3rd Floor, PCV, Floor, Jefferies Group, Antigen, GLOBE, Cantor, Needham & Company, Infection, LLC, Attention, Genetically modified bacteria, Equity capital markets, Telephone, SAN, Periodontal disease, Guggenheim, Sale, Exercise

Vaxcyte is selling 15,000,000 shares of common stock and pre-funded warrants to purchase 3,750,000 shares of common stock in the offering.

Key Points: 
  • Vaxcyte is selling 15,000,000 shares of common stock and pre-funded warrants to purchase 3,750,000 shares of common stock in the offering.
  • The shares of common stock are being sold at a public offering price of $32.00 per share, and the pre-funded warrants are being sold at a public offering price of $31.999 per underlying share.
  • The aggregate gross proceeds to Vaxcyte from this offering are expected to be approximately $600.0 million, before deducting underwriting discounts and commissions and other offering expenses, and excluding the exercise of any pre-funded warrants.
  • All shares of common stock and pre-funded warrants to be sold in the offering will be offered by Vaxcyte.

Dealer-Pay’s Payment Acceptance, Alongside DealerBuilt DMS, is Designed to Increase CSI Scores and Customer Retention

Retrieved on: 
Thursday, October 27, 2022
Technology, Payments, Automotive, General Automotive, Other Technology, Electronic Commerce, Automotive Manufacturing, Software, Manufacturing, Data Management, 808, Time, EVP, DMS, Efficiency, Sale, Solution, Controller, Industry, Technology, Philosophy, Dealership management system, President, Contract, POS, Financial services, Online shopping, Security (finance), Car dealership

This integration provides DealerBuilt with Dealer-Pays advanced payment tools that can be used across the entire dealership department to capture frictionless customer payments.

Key Points: 
  • This integration provides DealerBuilt with Dealer-Pays advanced payment tools that can be used across the entire dealership department to capture frictionless customer payments.
  • This addition is highly successful, as it retrieves data real-time from DealerBuilt to use for business and consumer payment acceptance.
  • The technology relationship between Dealer-Pay and DealerBuilt is a series of application programming interactions designed to increase user productivity, reduce data entry/errors, and reduce chargebacks in each department.
  • Call 800.226.1007 or visit https://www.dealer-pay.com/
    About DealerBuilt: DealerBuilt is an enterprise Dealer Management System (DMS) provider for retail automobile dealerships.

Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants

Retrieved on: 
Monday, October 24, 2022
808, SAN, Sutro Biopharma, Floor, U.S. Securities and Exchange Commission, Equity capital markets, Sale, Telephone, SEC, Vaccine, Infection, LLC, Jefferies Group, Madison Avenue, Security (finance), Periodontal disease, Attention, Bank of America, Company, BofA Securities, Needham & Company, State Street, Guggenheim Partners, Cantor, GLOBE, Genetically modified bacteria, Prospectus, Jefferies, Antigen, 3rd Floor, PCV, Guggenheim

All shares of common stock and pre-funded warrants to be sold in the offering will be offered by Vaxcyte.

Key Points: 
  • All shares of common stock and pre-funded warrants to be sold in the offering will be offered by Vaxcyte.
  • Vaxcyte intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of its common stock offered in the public offering (including shares underlying the pre-funded warrants).
  • BofA Securities, Jefferies, SVB Securities, Evercore ISI and Guggenheim Securities are acting as joint book-running managers for the offering.
  • Vaxcyte is driven to eradicate or treat invasive bacterial infections, which have serious and costly health consequences when left unchecked.

Helping Hand for Relief and Development Partners with Pakistani American Law Enforcement Society to Benefit Flood Victims

Retrieved on: 
Tuesday, October 25, 2022
808, International, PALS, Disability, Development, ID, Health care, Empowerment, Partnership, NYPD, Annual Filing Season Program, Physical therapy, INGO, HELP, Education

BROOKLYN, N.Y., Oct. 25, 2022 /PRNewswire/ -- Helping Hand for Relief and Development is proud to announce partnership with the Pakistani American Law Enforcement Society (PALS) to provide needed aid to flood victims in Pakistan.

Key Points: 
  • BROOKLYN, N.Y., Oct. 25, 2022 /PRNewswire/ -- Helping Hand for Relief and Development is proud to announce partnership with the Pakistani American Law Enforcement Society (PALS) to provide needed aid to flood victims in Pakistan.
  • PALS members of the NYPD have been collecting donations at precincts across New York City for HHRD to ship to Pakistan.
  • Today, members of PALS will be arriving in Pakistan to witness Helping Hand's work on the ground.
  • The law enforcement officers will be traveling with Helping Hand's team across the country to visit medical camps, goods distributions, and other projects.

InvestmentPitch Media Video Discusses K9 Gold’s Results from its 2022 Diamond Drill Program at the Jumper's Pond in Central Newfoundland, Intersecting 1.52 g/t Gold over 31.75 metres

Retrieved on: 
Thursday, October 20, 2022
808, News, Moosehead, CFO, Risk, Queensway, Marathon, Awareness, Cape, Gold, Suggestion, GLOBE, Jumper, Public relations, Road, Diocese of Central Newfoundland

Results show multiple well mineralized zones were encountered with significant widths of continuous gold mineralization present in many of the holes drilled during the 2022 campaign.

Key Points: 
  • Results show multiple well mineralized zones were encountered with significant widths of continuous gold mineralization present in many of the holes drilled during the 2022 campaign.
  • If these links are not enabled, please visit www.InvestmentPitch.com and enter K9 Gold in the search box.
  • The drill program, at Jumpers Pond, consisted of 8 diamond drill holes, for a total of 2,919 metres.
  • K9 Gold has paid a fee not exceeding $2,000 in cash to have its current news release produced in video format.

VectivBio Announces Closing of $125 Million Underwritten Offering of Ordinary Shares

Retrieved on: 
Tuesday, October 18, 2022
808, U.S. Securities and Exchange Commission, MMA, Sale, Telephone, SEC filing, SEC, SBS, Short bowel syndrome, Coenzyme A, Nicollet Mall, LLC, Pantetheine, Jefferies Group, Risk, Patient, Manufacturing execution system, Madison Avenue, Degenerative disease, Attention, Nasdaq, Richard Driehaus, State Street, Community of Metros, Form, Propionic acidemia, Congenital disorders of amino acid metabolism, Phrase, GLOBE, Prospectus, Jefferies, Respiration (physiology), Forward-looking statement, Life insurance, Security (finance), Citadel

BASEL, Switzerland, Oct. 18, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (VectivBio) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the closing of its previously announced underwritten offering of 16,700,000 ordinary shares at an offering price of $7.50 per share.

Key Points: 
  • BASEL, Switzerland, Oct. 18, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (VectivBio) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the closing of its previously announced underwritten offering of 16,700,000 ordinary shares at an offering price of $7.50 per share.
  • Before deducting the underwriting discounts and commissions and offering expenses, VectivBio received total gross proceeds of approximately $125 million.
  • Jefferies, SVB Securities and Piper Sandler acted as the joint book-running managers for the offering.
  • VectivBio is a global clinical-stage biotechnology company focused on transforming and improving the lives of patients with severe rare conditions.

DICE Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Monday, October 17, 2022
808, SAN, U.S. Securities and Exchange Commission, Floor, DICE, Equity capital markets, Sale, Telephone, Therapy, SEC, Form S-3, LLC, Madison Avenue, Security (finance), Attention, Nasdaq, BofA Securities, Exercise, Idiopathic pulmonary fibrosis, State Street, PPI, Form, Conditional sentence, Guggenheim Partners, GLOBE, Prospectus, IL-17, Inflammatory bowel disease, 3rd Floor, Guggenheim, Pharmaceutical industry

The gross proceeds to DICE from the offering, before deducting underwriting discounts and commissions and other offering expenses, were approximately $345.0 million.

Key Points: 
  • The gross proceeds to DICE from the offering, before deducting underwriting discounts and commissions and other offering expenses, were approximately $345.0 million.
  • BofA Securities, SVB Securities, Evercore ISI and Guggenheim Securities acted as the joint book-running managers for the offering.
  • The offering was made only by means of a prospectus and prospectus supplement that form a part of the registration statement.
  • DICE is also developing oral therapeutic candidates targeting 47 integrin and V1/V6 integrin for the treatment of inflammatory bowel disease and idiopathic pulmonary fibrosis, respectively.

Price Satisfaction Biggest Contributor to Decrease in Gas Utility Business Satisfaction, J.D. Power Finds

Retrieved on: 
Wednesday, October 19, 2022
Energy, Other Energy, Utilities, Oil, Gas, 808, Intelligence, J.D. Power, Perception, Industry, Consumer, Big data, Artificial intelligence, Safety, Retail

Power 2022 U.S. Gas Utility Business Customer Satisfaction Study, released today.

Key Points: 
  • Power 2022 U.S. Gas Utility Business Customer Satisfaction Study, released today.
  • To mitigate this issue, gas utility companies can benefit by updating their messaging to show the value of gas.
  • The following utilities rank highest in customer satisfaction in their respective region:
    Now in its 18th year, the U.S. Gas Utility Business Customer Satisfaction Study measures business customer satisfaction with gas utility companies in four regions: East, Midwest, South and West.
  • For more information about the U.S. Gas Utility Business Customer Satisfaction Study, visit https://www.jdpower.com/business/utilities/gas-utility-business-customer... .

Kōloa Landing Resort’s Kaua‘i is For Kids Program to Launch Nov. 1

Retrieved on: 
Tuesday, October 18, 2022
Lodging, Destinations, Travel, Vacation, Children, Family, Consumer, Tourist Attractions, 808, Volleyball, Map, Guangzhou Sunac Land Resort, Multimedia, Amusement park, Kid

Kloa Landing Resort announced its Kauai is For Kids program encouraging keiki (kids) to adventure around the resort and learn fun facts about sugarcane and its long history in Kloa.

Key Points: 
  • Kloa Landing Resort announced its Kauai is For Kids program encouraging keiki (kids) to adventure around the resort and learn fun facts about sugarcane and its long history in Kloa.
  • View the full release here: https://www.businesswire.com/news/home/20221018005562/en/
    Koloa Landing Resort's Kauai is For Kids program to launch Nov. 1.
  • Sugarcane is what makes Kloa Landing Resort unique and families will have the opportunity to experience this in a fun and educational way through our Kauai is for Kids program.
  • For more information about the Kauai is For Kids program, visit koloalandingresort.com/kauai-is-for-kids-dv/ .